A

Aquestive Therapeutics
D

AQST

3.12000
USD
-0.01
(-0.32%)
مغلق
حجم التداول
18,683
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
284,475,962
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BHC
    0.09000
    (1.17%)
    7.81500 USD
    B
    BMRN
    0.063
    (0.10%)
    62.090 USD
    L
    LQDT
    0.274
    (0.76%)
    36.130 USD
    L
    LXRX
    0.04100
    (4.83%)
    0.89000 USD
    O
    OMER
    -0.28500
    (-3.07%)
    9.01000 USD
    S
    SUPN
    0.440
    (1.15%)
    38.650 USD
    V
    VKTX
    0.870
    (2.55%)
    34.930 USD
    المزيد
الأخبار
المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.